Response to Intermediate stage treatment: Is TACE enough?

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|38|1|188-189

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.38, Iss.1, 2018-01, pp. : 188-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Intermediate stage treatment: Is TACE enough?

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 1, 2018-01 ,pp. : 187-187

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment Algorithm for Intermediate and Advanced Stage Hepatocellular Carcinoma: Korea

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 141-147

Karger

Access to resources Recommend Favorite

Treatment Strategies of Intermediate-Stage Hepatocellular Carcinomas in Japan (Barcelona Clinic Liver Cancer Stage B)

By  

Oncology, Vol. 87, Iss. 1, 2014-11 ,pp. : 78-81

Karger

Access to resources Recommend Favorite

Is drug‐eluting bead transcatheter arterial chemoembolization (TACE) associated with better tumor response than conventional TACE in meta‐analysis?

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 12, 2015-12 ,pp. : 1258-1259

John Wiley & Sons Inc

Access to resources Recommend Favorite

Previous Chemoembolization Response after Transcatheter Arterial Chemoembolization (TACE) Can Predict the Anti-Tumor Effect of Subsequent TACE with Miriplatin in Patients with Recurrent Hepatocellular Carcinoma

By  

Oncology, Vol. 80, Iss. 3-4, 2011-06 ,pp. : 188-194

Karger

Access to resources Recommend Favorite